749192-64-1 Usage
Uses
Used in Pharmaceutical Synthesis:
(3R,4R)-Ethyl 4-phenylpiperidine-3-carboxylate is used as an intermediate in the synthesis of various pharmaceuticals for its unique structural features and reactivity. Its presence in the synthesis process can contribute to the development of new drugs with specific therapeutic effects.
Used in Research Chemicals:
In the field of scientific research, (3R,4R)-Ethyl 4-phenylpiperidine-3-carboxylate serves as a valuable research chemical. It aids researchers in understanding the structure-activity relationships of different compounds and can be instrumental in the discovery of novel therapeutic agents.
Used in Psychoactive Substances:
(3R,4R)-Ethyl 4-phenylpiperidine-3-carboxylate may be utilized as a psychoactive substance due to its potential effects on the central nervous system. Its precise role and mechanism of action would require further investigation to fully understand its impact and applications in this area.
Used as a Precursor in Synthesis:
(3R,4R)-Ethyl 4-phenylpiperidine-3-carboxylate also holds potential as a precursor for the synthesis of other psychoactive compounds. Its unique structure and reactivity make it a candidate for further chemical modifications, leading to the creation of new substances with various psychotropic properties.
Check Digit Verification of cas no
The CAS Registry Mumber 749192-64-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,4,9,1,9 and 2 respectively; the second part has 2 digits, 6 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 749192-64:
(8*7)+(7*4)+(6*9)+(5*1)+(4*9)+(3*2)+(2*6)+(1*4)=201
201 % 10 = 1
So 749192-64-1 is a valid CAS Registry Number.
InChI:InChI=1/C14H19NO2/c1-2-17-14(16)13-10-15-9-8-12(13)11-6-4-3-5-7-11/h3-7,12-13,15H,2,8-10H2,1H3/t12-,13-/m0/s1
749192-64-1Relevant articles and documents
Synthesis and Discovery of Arylpiperidinylquinazolines: New Inhibitors of the Vesicular Monoamine Transporter
Provencher, Brian A.,Eshleman, Amy J.,Johnson, Robert A.,Shi, Xiao,Kryatova, Olga,Nelson, Jared,Tian, Jianhua,Gonzalez, Mario,Meltzer, Peter C.,Janowsky, Aaron
, p. 9121 - 9131 (2018/10/20)
Methamphetamine, a human vesicular monoamine transporter 2 (VMAT2) substrate, releases dopamine, serotonin, and norepinephrine from vesicles into the cytosol of presynaptic neurons and induces reverse transport by the monoamine transporters to increase ex
VMAT INHIBITORY COMPOUNDS
-
Paragraph 0211-0214, (2016/04/01)
Disclosed herein are compounds that bind to the vesicular monoamine transporter 2 (VMAT2), pharmaceutical compositions comprising those compounds, and methods of treatment using said compounds and pharmaceutical compositions.
Derives alkyles et aryles de l'acide nipecotique: synthese et appreciation de l'activite inhibitrice de la capture du GABA en fonction de parametres conformationnels et de biodisponibilite
Lapuyade, Gerard,Schlewer, Gilbert,N'Goka, Victor,Vernieres, Jean-Claude,Chambon, Jean-Pierre,et al.
, p. 383 - 392 (2007/10/02)
Alkyl and aryl derivatives of nipecotic acid: synthesis and inhibition of GABA uptake as a function of conformational parameters and bioavailability.Analogs of nipecotic acid, substituted at positions 2, 3, 4, 5, or 6 with a methyl or phenyl group were pr